The need for effective osteoporosis screening tools and treatment strategies is high, as the current methods have a low sensitivity for determining postmenopausal women at risk for a major osteoporotic fracture.
A study was conducted to assess the safety, tolerability, and efficacy of methyl estradiolpropanoate, a topical soft estrogen cosmeceutical for the treatment of estrogen-deficient skin.
Postmenopausal women with normal BMI and elevated body fat levels are at increased risk of breast cancer.
Women born during the Chinese famine period may be at increased risk for early natural menopause and premature ovarian failure.
To investigate the association between hormone therapy and carpal tunnel syndrome risk, researchers conducted a secondary analysis of the Women's Health Initiative (WHI) hormone therapy trials.
Women who undergo surgical menopause have significantly worse sleep quality than those who experience natural menopause.
History of sexual assault and current PTSD also associated with higher risk for menopause symptoms.
Severity of symptoms of vulvovaginal atrophy in postmenopausal women was found to have an impact on quality of life.
A diet high in fruits, vegetables, nuts, and legumes was found to be associated with a lower risk for physical, mental, and genitourinary symptoms of menopause compared with a diet high in fats, meats, desserts, and salts.
Early age of menopause development is associated with lower overall life expectancy and fewer years of life without diabetes.
Functional disability progressed more rapidly in postmenopausal compared with premenopausal women with rheumatoid arthritis.
Tissue-Selective Estrogen Complex May Benefit Postmenopausal Women With Vaginal Bleeding, Breast DiscomfortNovember 09, 2018
Switching to tissue-selective estrogen complex from hormone therapy may benefit women with breast discomfort or vaginal bleeding.
Approval from the Food and Drug Administration (FDA) was supported by the Phase 3 Replenish trial which evaluated the safety and efficacy of Bijuva in generally healthy, postmenopausal women with a uterus for the treatment of moderate to severe hot flashes.
Higher levels of estradiol were inversely associated with carotid artery intima-media thickness progression in the early postmenopausal cohort but positively associated with it in the late postmenopausal group.
Postmenopausal women with weight loss have a reduced risk for breast cancer.
Hypertensive disorders of pregnancy and gestational diabetes may increase the risk for hot flashes during menopause.
Light treatments successfully corrected abnormal timing of melatonin circadian rhythms in perimenopausal women with depression and improved mood and sleep within 2 weeks.
Researchers concluded that physical activity was not associated with risk for early menopause.
According to the Imvexxy prescribing information, women should generally be started at the 4mcg dosage strength with dosage adjustment guided by clinical response.
The 5 topics addressed by the 11-member expert panel include epidemiology, clinical presentation, therapeutic effects of antidepressants, effects of hormone therapy, and the effectiveness of other therapies (eg, psychotherapy, exercise, natural health products).
Stroke risk 19% lower with breastfeeding for 1 to 6 months; stronger link for longer duration.
The International Society for the Study of Women's Sexual Health convened an expert consensus panel to discuss the use of androgens in the management of genitourinary syndrome of menopause.
Investigators examined the relationship between menstrual cycle characteristics in adolescence and early adulthood and the risk for early natural menopause.
No Impact on Carotid Artery Intima-Media Thickness Following Cessation of Menopausal Hormone TherapyAugust 13, 2018
A follow-up study from KEEPS found that cessation of menopausal hormone therapy did not change the expected trajectory of carotid artery intima-media thickness over a 3-year period.
The insulin sensitivity in post- and premenopausal women along with lipid deposition in the liver and skeletal muscle was examined.
This retrospective study sought to assess migraine patterns in 69 menopausal women between ages 40 and 60 who were treated at Partners Healthcare Hospitals for concurrent migraine headache.
Women prescribed long- vs short-term opioids for chronic musculoskeletal pain may be at increased risk for menopause and abnormal menstruation.
Hormone therapy in postmenopausal women with mild cognitive impairment was examined.
No Additional Benefits With Vaginal Estradiol Tablets, Moisturizers for Postmenopausal Vulvovaginal SymptomsJune 14, 2018
Prescribed vaginal estradiol tablets and over-the-counter vaginal moisturizers may not be more effective than placebos for postmenopausal vulvovaginal symptoms.
Equol-containing nutraceuticals may be beneficial for postmenopausal women with vaginal symptoms.